Bay Bridge Capital Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Bay Bridge Capital Group, LLC
- $161 Billion
- Q4 2025
A detailed history of Bay Bridge Capital Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bay Bridge Capital Group, LLC holds 421 shares of REGN stock, worth $291,963. This represents 0.2% of its overall portfolio holdings.
Number of Shares
421
Previous 416
1.2%
Holding current value
$291,963
Previous $234 Million
38.93%
% of portfolio
0.2%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,528Shares Held
86.5MCall Options Held
2.38MPut Options Held
1.6M-
Vanguard Group Inc Valley Forge, PA9.08MShares$6.29 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...